The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pril-series Drugs Market Research Report 2025
Synopsis
Pril-series drugs are one of the commonly used antihypertensive drugs in clinical practice, ending with "Pril", such as perindopril and enalapril. Pril-series drugs are called Angiotensin-converting enzyme (ACE) inhibitors, are medicines that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from making angiotensin 2, a substance that narrows blood vessels. This narrowing can cause high blood pressure and forces the heart to work harder.
The global Pril-series Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pril-series Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pril-series Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pril-series Drugs in Hospital Pharmaty is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pril-series Drugs include Servier, Sanofi, Novartis, Bristol-Myers Squibb Company, Pfizer, TAD Pharma, Organon Pharma, Huahai Pharmaceutical, Kunshan Rotam Reddy Pharmaceutical, Shenzhen Salubris Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pril-series Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pril-series Drugs.
The Pril-series Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pril-series Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pril-series Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Servier
Sanofi
Novartis
Bristol-Myers Squibb Company
Pfizer
TAD Pharma
Organon Pharma
Huahai Pharmaceutical
Kunshan Rotam Reddy Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Segment by Type
Enalapril
Lisinopril
Captopril
Ramipril
Perindopril
Others
Segment by Application
Hospital Pharmaty
Retail Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pril-series Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pril-series drugs are one of the commonly used antihypertensive drugs in clinical practice, ending with "Pril", such as perindopril and enalapril. Pril-series drugs are called Angiotensin-converting enzyme (ACE) inhibitors, are medicines that help relax the veins and arteries to lower blood pressure. ACE inhibitors prevent an enzyme in the body from making angiotensin 2, a substance that narrows blood vessels. This narrowing can cause high blood pressure and forces the heart to work harder.
The global Pril-series Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pril-series Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pril-series Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pril-series Drugs in Hospital Pharmaty is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pril-series Drugs include Servier, Sanofi, Novartis, Bristol-Myers Squibb Company, Pfizer, TAD Pharma, Organon Pharma, Huahai Pharmaceutical, Kunshan Rotam Reddy Pharmaceutical, Shenzhen Salubris Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pril-series Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pril-series Drugs.
The Pril-series Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pril-series Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pril-series Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Servier
Sanofi
Novartis
Bristol-Myers Squibb Company
Pfizer
TAD Pharma
Organon Pharma
Huahai Pharmaceutical
Kunshan Rotam Reddy Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Segment by Type
Enalapril
Lisinopril
Captopril
Ramipril
Perindopril
Others
Segment by Application
Hospital Pharmaty
Retail Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pril-series Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pril-series Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Enalapril
1.2.3 Lisinopril
1.2.4 Captopril
1.2.5 Ramipril
1.2.6 Perindopril
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pril-series Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmaty
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pril-series Drugs Market Perspective (2019-2030)
2.2 Global Pril-series Drugs Growth Trends by Region
2.2.1 Global Pril-series Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pril-series Drugs Historic Market Size by Region (2019-2024)
2.2.3 Pril-series Drugs Forecasted Market Size by Region (2025-2030)
2.3 Pril-series Drugs Market Dynamics
2.3.1 Pril-series Drugs Industry Trends
2.3.2 Pril-series Drugs Market Drivers
2.3.3 Pril-series Drugs Market Challenges
2.3.4 Pril-series Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pril-series Drugs Players by Revenue
3.1.1 Global Top Pril-series Drugs Players by Revenue (2019-2024)
3.1.2 Global Pril-series Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Pril-series Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pril-series Drugs Revenue
3.4 Global Pril-series Drugs Market Concentration Ratio
3.4.1 Global Pril-series Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pril-series Drugs Revenue in 2023
3.5 Global Key Players of Pril-series Drugs Head office and Area Served
3.6 Global Key Players of Pril-series Drugs, Product and Application
3.7 Global Key Players of Pril-series Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pril-series Drugs Breakdown Data by Type
4.1 Global Pril-series Drugs Historic Market Size by Type (2019-2024)
4.2 Global Pril-series Drugs Forecasted Market Size by Type (2025-2030)
5 Pril-series Drugs Breakdown Data by Application
5.1 Global Pril-series Drugs Historic Market Size by Application (2019-2024)
5.2 Global Pril-series Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pril-series Drugs Market Size (2019-2030)
6.2 North America Pril-series Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pril-series Drugs Market Size by Country (2019-2024)
6.4 North America Pril-series Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pril-series Drugs Market Size (2019-2030)
7.2 Europe Pril-series Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pril-series Drugs Market Size by Country (2019-2024)
7.4 Europe Pril-series Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pril-series Drugs Market Size (2019-2030)
8.2 Asia-Pacific Pril-series Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pril-series Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Pril-series Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pril-series Drugs Market Size (2019-2030)
9.2 Latin America Pril-series Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pril-series Drugs Market Size by Country (2019-2024)
9.4 Latin America Pril-series Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pril-series Drugs Market Size (2019-2030)
10.2 Middle East & Africa Pril-series Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pril-series Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Pril-series Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Servier
11.1.1 Servier Company Details
11.1.2 Servier Business Overview
11.1.3 Servier Pril-series Drugs Introduction
11.1.4 Servier Revenue in Pril-series Drugs Business (2019-2024)
11.1.5 Servier Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Pril-series Drugs Introduction
11.2.4 Sanofi Revenue in Pril-series Drugs Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Pril-series Drugs Introduction
11.3.4 Novartis Revenue in Pril-series Drugs Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Details
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Pril-series Drugs Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Pril-series Drugs Business (2019-2024)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Pril-series Drugs Introduction
11.5.4 Pfizer Revenue in Pril-series Drugs Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 TAD Pharma
11.6.1 TAD Pharma Company Details
11.6.2 TAD Pharma Business Overview
11.6.3 TAD Pharma Pril-series Drugs Introduction
11.6.4 TAD Pharma Revenue in Pril-series Drugs Business (2019-2024)
11.6.5 TAD Pharma Recent Development
11.7 Organon Pharma
11.7.1 Organon Pharma Company Details
11.7.2 Organon Pharma Business Overview
11.7.3 Organon Pharma Pril-series Drugs Introduction
11.7.4 Organon Pharma Revenue in Pril-series Drugs Business (2019-2024)
11.7.5 Organon Pharma Recent Development
11.8 Huahai Pharmaceutical
11.8.1 Huahai Pharmaceutical Company Details
11.8.2 Huahai Pharmaceutical Business Overview
11.8.3 Huahai Pharmaceutical Pril-series Drugs Introduction
11.8.4 Huahai Pharmaceutical Revenue in Pril-series Drugs Business (2019-2024)
11.8.5 Huahai Pharmaceutical Recent Development
11.9 Kunshan Rotam Reddy Pharmaceutical
11.9.1 Kunshan Rotam Reddy Pharmaceutical Company Details
11.9.2 Kunshan Rotam Reddy Pharmaceutical Business Overview
11.9.3 Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Introduction
11.9.4 Kunshan Rotam Reddy Pharmaceutical Revenue in Pril-series Drugs Business (2019-2024)
11.9.5 Kunshan Rotam Reddy Pharmaceutical Recent Development
11.10 Shenzhen Salubris Pharmaceuticals
11.10.1 Shenzhen Salubris Pharmaceuticals Company Details
11.10.2 Shenzhen Salubris Pharmaceuticals Business Overview
11.10.3 Shenzhen Salubris Pharmaceuticals Pril-series Drugs Introduction
11.10.4 Shenzhen Salubris Pharmaceuticals Revenue in Pril-series Drugs Business (2019-2024)
11.10.5 Shenzhen Salubris Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Pril-series Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Enalapril
Table 3. Key Players of Lisinopril
Table 4. Key Players of Captopril
Table 5. Key Players of Ramipril
Table 6. Key Players of Perindopril
Table 7. Key Players of Others
Table 8. Global Pril-series Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Pril-series Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Pril-series Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Pril-series Drugs Market Share by Region (2019-2024)
Table 12. Global Pril-series Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Pril-series Drugs Market Share by Region (2025-2030)
Table 14. Pril-series Drugs Market Trends
Table 15. Pril-series Drugs Market Drivers
Table 16. Pril-series Drugs Market Challenges
Table 17. Pril-series Drugs Market Restraints
Table 18. Global Pril-series Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Pril-series Drugs Market Share by Players (2019-2024)
Table 20. Global Top Pril-series Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pril-series Drugs as of 2023)
Table 21. Ranking of Global Top Pril-series Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Pril-series Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Global Key Players of Pril-series Drugs, Headquarters and Area Served
Table 24. Global Key Players of Pril-series Drugs, Product and Application
Table 25. Global Key Players of Pril-series Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pril-series Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Pril-series Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Pril-series Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Pril-series Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Pril-series Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Pril-series Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Pril-series Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Pril-series Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Pril-series Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Pril-series Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Pril-series Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Pril-series Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Pril-series Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Pril-series Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Pril-series Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Pril-series Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Pril-series Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Pril-series Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pril-series Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Servier Company Details
Table 51. Servier Business Overview
Table 52. Servier Pril-series Drugs Product
Table 53. Servier Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)
Table 54. Servier Recent Development
Table 55. Sanofi Company Details
Table 56. Sanofi Business Overview
Table 57. Sanofi Pril-series Drugs Product
Table 58. Sanofi Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)
Table 59. Sanofi Recent Development
Table 60. Novartis Company Details
Table 61. Novartis Business Overview
Table 62. Novartis Pril-series Drugs Product
Table 63. Novartis Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Bristol-Myers Squibb Company Company Details
Table 66. Bristol-Myers Squibb Company Business Overview
Table 67. Bristol-Myers Squibb Company Pril-series Drugs Product
Table 68. Bristol-Myers Squibb Company Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)
Table 69. Bristol-Myers Squibb Company Recent Development
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Pril-series Drugs Product
Table 73. Pfizer Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)
Table 74. Pfizer Recent Development
Table 75. TAD Pharma Company Details
Table 76. TAD Pharma Business Overview
Table 77. TAD Pharma Pril-series Drugs Product
Table 78. TAD Pharma Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)
Table 79. TAD Pharma Recent Development
Table 80. Organon Pharma Company Details
Table 81. Organon Pharma Business Overview
Table 82. Organon Pharma Pril-series Drugs Product
Table 83. Organon Pharma Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)
Table 84. Organon Pharma Recent Development
Table 85. Huahai Pharmaceutical Company Details
Table 86. Huahai Pharmaceutical Business Overview
Table 87. Huahai Pharmaceutical Pril-series Drugs Product
Table 88. Huahai Pharmaceutical Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)
Table 89. Huahai Pharmaceutical Recent Development
Table 90. Kunshan Rotam Reddy Pharmaceutical Company Details
Table 91. Kunshan Rotam Reddy Pharmaceutical Business Overview
Table 92. Kunshan Rotam Reddy Pharmaceutical Pril-series Drugs Product
Table 93. Kunshan Rotam Reddy Pharmaceutical Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)
Table 94. Kunshan Rotam Reddy Pharmaceutical Recent Development
Table 95. Shenzhen Salubris Pharmaceuticals Company Details
Table 96. Shenzhen Salubris Pharmaceuticals Business Overview
Table 97. Shenzhen Salubris Pharmaceuticals Pril-series Drugs Product
Table 98. Shenzhen Salubris Pharmaceuticals Revenue in Pril-series Drugs Business (2019-2024) & (US$ Million)
Table 99. Shenzhen Salubris Pharmaceuticals Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Authors List of This Report
List of Figures
Figure 1. Pril-series Drugs Picture
Figure 2. Global Pril-series Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pril-series Drugs Market Share by Type: 2023 VS 2030
Figure 4. Enalapril Features
Figure 5. Lisinopril Features
Figure 6. Captopril Features
Figure 7. Ramipril Features
Figure 8. Perindopril Features
Figure 9. Others Features
Figure 10. Global Pril-series Drugs Market Size by Application (2024-2030) & (US$ Million)
Figure 11. Global Pril-series Drugs Market Share by Application: 2023 VS 2030
Figure 12. Hospital Pharmaty Case Studies
Figure 13. Retail Pharmacy Case Studies
Figure 14. Pril-series Drugs Report Years Considered
Figure 15. Global Pril-series Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Pril-series Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Pril-series Drugs Market Share by Region: 2023 VS 2030
Figure 18. Global Pril-series Drugs Market Share by Players in 2023
Figure 19. Global Top Pril-series Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pril-series Drugs as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Pril-series Drugs Revenue in 2023
Figure 21. North America Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Pril-series Drugs Market Share by Country (2019-2030)
Figure 23. United States Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Pril-series Drugs Market Share by Country (2019-2030)
Figure 27. Germany Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Pril-series Drugs Market Share by Region (2019-2030)
Figure 35. China Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Pril-series Drugs Market Share by Country (2019-2030)
Figure 43. Mexico Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Pril-series Drugs Market Share by Country (2019-2030)
Figure 47. Turkey Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. UAE Pril-series Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Servier Revenue Growth Rate in Pril-series Drugs Business (2019-2024)
Figure 51. Sanofi Revenue Growth Rate in Pril-series Drugs Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Pril-series Drugs Business (2019-2024)
Figure 53. Bristol-Myers Squibb Company Revenue Growth Rate in Pril-series Drugs Business (2019-2024)
Figure 54. Pfizer Revenue Growth Rate in Pril-series Drugs Business (2019-2024)
Figure 55. TAD Pharma Revenue Growth Rate in Pril-series Drugs Business (2019-2024)
Figure 56. Organon Pharma Revenue Growth Rate in Pril-series Drugs Business (2019-2024)
Figure 57. Huahai Pharmaceutical Revenue Growth Rate in Pril-series Drugs Business (2019-2024)
Figure 58. Kunshan Rotam Reddy Pharmaceutical Revenue Growth Rate in Pril-series Drugs Business (2019-2024)
Figure 59. Shenzhen Salubris Pharmaceuticals Revenue Growth Rate in Pril-series Drugs Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
